Craig Lambert

Craig Lambert

UNVERIFIED PROFILE

Are you Craig Lambert?   Register this Author

Register author
Craig Lambert

Craig Lambert

Publications by authors named "Craig Lambert"

Are you Craig Lambert?   Register this Author

5Publications

162Reads

9Profile Views

Percutaneous coronary intervention still not accessible for many South Africans.

Afr J Emerg Med 2017 Sep 19;7(3):105-107. Epub 2017 Apr 19.

Department of Clinical Research and Education, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.afjem.2017.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234190PMC
September 2017

Managing the Risk of CYP3A Induction in Drug Development: A Strategic Approach.

Drug Metab Dispos 2017 01 24;45(1):35-41. Epub 2016 Oct 24.

Oncology Innovative Medicines and Early Development Biotech Unit (B.C.J.) and Drug Safety and Metabolism (H.R.), AstraZeneca, Cambridge, United Kingdom; Quantitative Clinical Pharmacology (S.J.), and Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit (K.P.K., T.B.A.), AstraZeneca, Mölndal, Sweden; Quantitative Clinical Pharmacology, AstraZeneca, Hertfordshire, United Kingdom (C.L.); Quantitative Clinical Pharmacology, AstraZeneca, Waltham, Massachusetts (K.V.); and Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden (T.B.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.116.072025DOI Listing
January 2017

Managing the challenge of chemically reactive metabolites in drug development.

Nat Rev Drug Discov 2011 Apr;10(4):292-306

MRC Centre for Drug Safety Science, Division of Molecular & Clinical Pharmacology, The Institute of Translational Medicine, University of Liverpool, Liverpool L693GE, UK. ac.uk

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrd3408DOI Listing
April 2011

Acyl glucuronides: the good, the bad and the ugly.

Biopharm Drug Dispos 2010 Oct;31(7):367-95

MRC Centre for Drug Safety Science, Institute of Translational Medicine, The University of Liverpool, Liverpool L69 3GE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdd.720DOI Listing
October 2010